• Subject: Re: CA/400 for Windows 95/NT 3.1.2
  • From: Glenn Gundermann <ggundermann@xxxxxxx>
  • Date: Mon, 24 Nov 1997 17:09:24 GMT

Peter,

We were told not to use the 32-bit Novell NetWare Client but to use the
Microsoft Netware Client.  We are stable on Windows 95 (all versions),
Internet, Novell NetWare and Client Access using Netsoft Router.

Glenn

At 03:18 PM 11/21/97 EDT, you wrote:
>We are running CA/400 For Windows 95/NT 3.1.2 on our Windows 95 
>machines.  We connect to the AS/400 using an Ethernet connection, MS 
>32-bit DLC and NS/Router.
>
>As well, our users need to access a Netware server and the Internet.
>
>We've tried running CA/400 with various versions of Windows 95, and 
>various versions of the 32-bit Netware client and TCP/IP.
>
>But we aren't satisfied with the stability of any of the 
>configurations.
>
>(OK, OK, we should be using NT or OS/2!)  
>
>Assuming that we want to run Windows 95 on some of our PC's, has 
>anyone found a mixture of the various versions of Windows 95, Netware 
>client and CA/400 that seems to be stable and reliable??

    _/_/_/_/   _/         _/_/_/_/   _/_/    _/   _/_/    _/
   _/         _/         _/         _/ _/   _/   _/ _/   _/
  _/  _/_/   _/         _/_/_/     _/  _/  _/   _/  _/  _/
 _/    _/   _/         _/         _/   _/ _/   _/   _/ _/
_/_/_/_/   _/_/_/_/   _/_/_/_/   _/    _/_/   _/    _/_/

Glenn Gundermann
ggundermann@ibm.net
work tel: (416) 967-8222
cel:      (416) 409-4551

+---
| This is the Midrange System Mailing List!
| To submit a new message, send your mail to "MIDRANGE-L@midrange.com".
| To unsubscribe from this list send email to MIDRANGE-L-UNSUB@midrange.com.
| Questions should be directed to the list owner/operator: david@midrange.com
+---


This thread ...


Follow On AppleNews
Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2019 by midrange.com and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available on our policy page. If you have questions about this, please contact [javascript protected email address].